Covered recipient · General Payments record
RICHARD J NOWAK
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$118,491.08
- Reported across 126 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $26,881.50 | 8 |
| Travel and Lodging | $2,481.01 | 10 |
| Food and Beverage | $508.28 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | $12,718.62 | 5 |
| Amgen Inc. | $8,431.01 | 12 |
| Janssen Global Services, LLC | $5,737.50 | 2 |
| Janssen Biotech, Inc. | $2,025.00 | 1 |
| ARGENX US, INC. | $758.26 | 3 |
| UCB, Inc. | $200.40 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $1,180.00 | 02/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093959823 | CMS |
| Alexion Pharmaceuticals, Inc. | $6,490.00 | 07/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093886560 | CMS |
| Alexion Pharmaceuticals, Inc. | $280.85 | 10/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1093970738 | CMS |
| Alexion Pharmaceuticals, Inc. | $4,720.00 | 11/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093891980 | CMS |
| Alexion Pharmaceuticals, Inc. | $47.77 | 11/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1094019007 | CMS |
| Amgen Inc. | $111.91 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115974762 | CMS |
| Amgen Inc. | $299.79 | 04/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115974768 | CMS |
| Amgen Inc. | $39.48 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115974774 | CMS |
| Amgen Inc. | $397.44 | 04/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115974782 | CMS |
| Amgen Inc. | $3,429.00 | 04/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1115974788 | CMS |
| Amgen Inc. | $37.52 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115974794 | CMS |
| Amgen Inc. | $21.36 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115974800 | CMS |
| Amgen Inc. | $437.25 | 10/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115974806 | CMS |
| Amgen Inc. | $97.61 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115974812 | CMS |
| Amgen Inc. | $20.65 | 10/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115974841 | CMS |
| Amgen Inc. | $3,300.00 | 10/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1115974848 | CMS |
| Amgen Inc. | $239.00 | 10/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115974825 | CMS |
| ARGENX US, INC. | $505.42 | 02/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142113595 | CMS |
| ARGENX US, INC. | $38.00 | 02/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142114055 | CMS |
| ARGENX US, INC. | $214.84 | 02/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142115055 | CMS |
| Janssen Biotech, Inc. | $2,025.00 | 05/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1078380890 | CMS |
| Janssen Global Services, LLC | $3,037.50 | 05/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077590709 | CMS |
| Janssen Global Services, LLC | $2,700.00 | 11/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077590711 | CMS |
| UCB, Inc. | $42.50 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143443311 | CMS |
| UCB, Inc. | $23.85 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143443316 | CMS |
| UCB, Inc. | $134.05 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143443320 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.